Completed OBSERVATIONAL NCT06710262

T-TAS® wS Method Comparison

Sponsor: Hikari Dx, Inc.

Conditions Antiplatelet Therapy Healthy Donors Von Willebrand Disease (VWD)

Updated 3 times since 2024 Last updated: Jul 23, 2025 Started: Aug 21, 2024 Primary completion: Jul 14, 2025 Completion: Jul 14, 2025

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Antiplatelet Therapy and Healthy Donors and is currently completed. Hikari Dx, Inc. leads this study, which shows 3 recorded versions since 2024 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

3 versions recorded

Aug 2025 — Present [monthly]

Completed

Status: Recruiting → Completed
Apr 2025 — Aug 2025 [monthly]

Recruiting

Status: Not Yet Recruiting → Recruiting
Dec 2024 — Apr 2025 [monthly]

Not Yet Recruiting

First recorded

Aug 2024

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Hikari Dx, Inc.
ZACROS Corporation

Data source: Hikari Dx, Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Baltimore, United States
• Jacksonville, United States